Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 100: 1065-1076, 2006; doi:10.1152/japplphysiol.00793.2005
8750-7587/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leffler, C. W.
Right arrow Articles by Wang, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leffler, C. W.
Right arrow Articles by Wang, R.

INVITED REVIEW

HIGHLIGHTED TOPICS
Regulation of the Cerebral Circulation

Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation

Charles W. Leffler,1 Helena Parfenova,1 Jonathan H. Jaggar,1 and Rui Wang2

1Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee; and 2Department of Biology, Lakehead University, Thunder Bay, Ontario, Canada


    ABSTRACT
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This review focuses on two gaseous cellular messenger molecules, CO and H2S, that are involved in cerebrovascular flow regulation. CO is a dilatory mediator in active hyperemia, autoregulation, hypoxic dilation, and counteracting vasoconstriction. It is produced from heme by a constitutively expressed enzyme [heme oxygenase (HO)-2] expressed highly in the brain and by an inducible enzyme (HO-1). CO production is regulated by controlling substrate availability, HO-2 catalytic activity, and HO-1 expression. CO dilates arterioles by binding to heme that is bound to large-conductance Ca2+-activated K+ channels. This binding elevates channel Ca2+ sensitivity, that increases coupling of Ca2+ sparks to large-conductance Ca2+-activated K+ channel openings and, thereby, hyperpolarizes the vascular smooth muscle. In addition to dilating blood vessels, CO can either inhibit or accentuate vascular cell proliferation and apoptosis, depending on conditions. H2S may also function as a cerebrovascular dilator. It is produced in vascular smooth muscle cells by hydrolysis of L-cysteine catalyzed by cystathione {gamma}-lyase (CSE). H2S dilates arterioles at physiologically relevant concentrations via activation of ATP-sensitive K+ channels. In addition to dilating blood vessels, H2S promotes apoptosis of vascular smooth muscle cells and inhibits proliferation-associated vascular remodeling. Thus both CO and H2S modulate the function and the structure of circulatory system. Both the HO-CO and CSE-H2S systems have potential to interact with NO and prostanoids in the cerebral circulation. Much of the physiology and biochemistry of HO-CO and CSE-H2S in the cerebral circulation remains open for exploration.

flow regulation; large-conductance Ca2+-activated K+ channels; ATP-sensitive K+ channels; heme oxygenase; cystathione {gamma}-lyase


THE GROUP OF GASEOUS autocrine/paracrine messengers continues to expand and now includes nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide (H2S), and several molecules from the broad category of reactive oxygen species (ROS). Diverse functions of the messengers are being detected at an astounding rate, demonstrating that the gaseous autocrine/paracrine messengers are critical to vertebrate, and possibly all living organism, physiology and extend far beyond just NO. Gaseous messengers, or gasotransmitters (145), are employed for intra- and intercellular communication with high specificity in many, if not all, organ systems. Although gaseous messengers function analogously to hormones, neurotransmitters, and lipid mediators, they have distinct attributes. Because they are lipid-soluble gases, gasotransmitters are not constrained by cellular membranes. Thus storage in vesicles for later release is not possible. Although it has been suggested that CO and NO could be bound to heme-containing proteins that may be induced to release the messenger (27, 53, 141), clearly the predominant determination of the strength of signal of gasotransmitters is de novo synthesis. Because gasotransmitters diffuse down partial pressure gradients and are unconstrained by cell membranes, specific uptake or metabolizing processes to terminate the signals need not exist. Signals are terminated by falling concentrations upon reduction of production that are caused by reacting with cellular components (particularly ROS and NO), binding to cellular components (e.g., CO to ferrous heme), or diffusing away. The natures of the interactions of the gasotransmitters with their receptors are, with the exception of NO and guanylyl cyclase (GC), only beginning to be uncovered.

Although the overall category of gasotransmitters encompasses NO, CO, H2S, various ROS, and certainly others not yet realized, the present minireview will be limited to CO and H2S in regulation of cerebrovascular circulation, because roles of NO have been extensively discussed and reviewed before (35, 78, 121) and the understanding of signaling roles of ROS, as opposed to the destructive actions, is limited (for reviews, see Refs. 32, 44, 114).


    CARBON MONOXIDE
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Most information on contributions of endogenously produced CO to control of cerebrovascular circulation derives from studies on newborn pigs. Thus the review below is biased toward newborn pig cerebrovascular circulation. Far fewer data are available on CO in the cerebrovascular circulation from newborns of other species or, for the most part, adults of any species.

The following discussion is summarized pictorially in Fig. 1.


Figure 1
View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1. Flow chart summarizing the section of this review on carbon monoxide (CO). ALAS, {Delta}-aminolevulinic acid synthase; Ca/CM, calcium-calmodulin; HO, heme oxygenase; NO, nitric oxide; ROS, reactive oxygen species; KCa, Ca2+-activated K+ current.

 
Control of CO production.   The gas CO is produced physiologically by catabolism of heme to CO, iron, and biliverdin (94). This reaction is catalyzed by heme oxygenase (HO) with reduction of NADPH. HO is expressed as three known isoforms: HO-1, HO-2, and a third isoform (HO-3) with much lower heme-degrading activity (101) and low expression in the brain (129). Recent reports indicate that HO-3 genes are processed pseudogenes derived from HO-2 transcripts that have no known functional significance (47). In freshly isolated cerebral microvessels, as in the intact brain, in vivo, only HO-2 expression was detected on Western blots (117). The constitutive nature of HO-2 in the brain and brain vasculature requires mechanisms for regulation of CO production either by control of enzyme activity or substrate delivery. CO production by HO-2 could be controlled by delivery of electrons from NADPH via cytochrome P-450 reductase, by O2 availability, by delivery of heme to the enzyme, and by the catalytic activity of the enzyme.

Although evidence to indicate NADPH concentration or PO2 regulates CO production in the cerebral circulation has not been produced, data suggesting that O2 availability can affect CO production are available from other tissues. In microsomal fractions of human placenta chorionic villi, CO production is directly related to PO2 from 18 to 166 Torr (5). Also, electrophysiological results from membrane patches of carotid body glomus cells suggest that hypoxia may decrease CO production (77). However, hypoxia dilates cerebral arteries, as does CO, so the functional significance of hypoxic inhibition of CO production in the cerebral circulation is unknown.

Endogenous CO production by brain and brain vessels is substrate limited because provision of exogenous heme increases CO production (80). Therefore, mechanisms that regulate cellular heme production will also regulate CO production. Cellular heme manufacture is a multistep process that includes both mitochondrial and cytoplasmic elements, but the rate-limiting step is production in mitochondria of {delta}-aminolevulinic acid from succinyl CoA and glycine catalyzed by {delta}-aminolevulinic acid synthase (66, 100). {delta}-Aminolevulinic acid synthase activity is tightly regulated, being inhibited in a negative feedback manner by heme and hemin (oxidized heme). Control conceivably could also occur by regulation of ferrochelatase or porphobilinogen deaminase, but such control mechanisms have not been demonstrated. In intact cerebral microvessels, increasing cytosolic Ca2+ with ionomycin or activation of protein kinases C (PKC) with phorbol ester increased CO production by increasing heme availability (80). However, in neither case is the cellular mechanisms involved known.

HO-2 catalytic activity, i.e., CO production per amount of enzyme from exogenous heme, includes HO catalytic efficiency and activation by intracellular relocation. Negative feedback control of HO-2 catalytic activity by bilirubin has been described (93). Other control mechanisms of HO-2 catalytic activity may be cell type and tissue specific. For example, in neurons HO-2 activity can be stimulated by casein kinase II (CK2)-catalyzed phosphorylation of serine 79 (10). Glutamatergic activation of HO-2 results from metabotropic glutamate receptor-induced Ca2+ release, activation of PKC, and CK2 phosphorylation (12). Conversely, in freshly isolated piglet cerebral microvessels and microvascular endothelial cells in culture, CO production is increased by ionotropic, but not metabotropic, glutamate receptor stimulation (116) (see Protective effects of HO-CO and regulation of CBF during seizures below for more extensive discussion of glutamate receptors and CO). In addition, protein tyrosine kinase inhibition decreased and tyrosine phosphatase inhibition increased basal and glutamate-stimulated HO-2 catalytic activity and CO production (79). Furthermore, inhibition of neither PKC nor CK2 altered HO-2 catalytic activity (80, 81).

In cerebral microvessels and cortical neurons, calmidizolium, which inhibits calmodulin (CaM), decreased HO-2 catalytic activity and blocked glutamate stimulation of CO production (11, 81). Boehning et al. (11) demonstrated Ca2+- dependent CaM binding to HO-2 expressed in yeast. Ionomycin increased HO-2 activity and calmidizolium blocked the response to ionomycin in HEK-293 cells transfected with rat HO-2 gene. Interestingly, in cerebral microvessels we found that the Ca ionophore, ionomycin, in Ca2+-replete media increased CO production but did not detectably increase HO-2 catalytic activity, suggesting elevation of free heme as the major mechanism behind ionomycin-induced stimulation of CO production (81). Nevertheless, the results in both neurons and microvessels are consistent with HO-2 expressed in yeast showing calcium-calmodulin (Ca2+/CaM) regulation of HO-2 catalytic activity. The reasons for the apparent discrepancy between effects of cytosolic Ca2+ manipulation and those of CaM inhibition are not known.

Another gaseous mediator, NO, can affect HO-2 catalytic activity. HO-2 expressed in Escherichia coli is inhibited by NO donors via binding of NO to a heme regulatory motif on HO-2 (27). Also, a direct inhibitory effect of NO has been reported in HO-1-rich aortic endothelial cell microsomes where nitrosylation of heme prevented catabolism by HO (62). Conversely, in cerebral microvessels we found that NO increases HO-2 catalytic activity and thus CO production via a cGMP-dependent mechanism (80). The mechanism by which cGMP increases HO-2 activity is unknown, but it appears reasonable to suspect protein kinase G activation of tyrosine kinases or phosphatase inhibition (79, 81). Also, in isolated heart (99) and porcine aortic endothelial cells (108), NO increased CO production. It is possible that NO can have a direct inhibitory effect on HO-2 that is masked in the intact system by cGMP-induced stimulation.

Extravascular sources of CO in vivo may contribute to pial arteriolar dilation to glutamate. Of particular note, data on isolated vessels and those from intact cerebrovascular circulation in vivo are not entirely consistent. Thus, in isolated microvessels NO synthase (NOS) inhibition totally abolished glutamate-induced CO production (80). However, in vivo, whereas NOS inhibition blocked glutamate-induced dilation, a constant background amount of NO completely restored dilation to glutamate (71). If glutamate increases NO that increases CO, which is the final mediator of dilation, glutamate should not cause dilation if NO is held constant, but it does. In vivo, cerebral microvessels are accompanied by astrocytes and neurons that also have glutamate receptors (46, 54, 89), HO-2 (129), and neuronal NOS (nNOS) (157). In fact, involvement of nNOS in glutamate-induced cerebrovascular dilation in mouse cerebellum has been demonstrated (156). Furthermore, because both astrocytes and neurons have HO-2, glutamate could stimulate CO production in these cells. The dilator response to CO would still be endothelial dependent because the endothelium is necessary to provide the obligatory permissive signal of NO.

Localization of HO isoforms and regulation of HO-1 and HO-2 expression.   HO-1 and HO-2 isoforms are products of distinct genes located on different chromosomes. The amino acid sequences of HO-1 and HO-2 have only 40% similarity (13). Human HO-1 is a single polypeptide of 288 residues and ~32 kDa, whereas human HO-2 is a 316-residue protein (36 kDa) due to an addition at the NH4 terminus. A common 24-amino-acid domain that forms the heme catalytic pocket is evolutionally conserved in HO-1 and HO-2 except for a single amino acid residue (95). Catalytic mechanisms of heme degradation by the isoforms are similar.

Both HO-1 and HO-2 are membrane-bound proteins anchored to the endoplasmic reticulum membrane via a COOH-terminal hydrophobic tail (130). In porcine cerebral vascular endothelial cells, HO-1 and HO-2 have similar intracellular localization with strong preference for the nuclear envelope, perinuclear area of the cytoplasm, and endoplasmic reticulum (117). Electron immunocytochemistry data in rat kidney epithelial cells also demonstrated association of HO-2 with the nuclear outer membrane and the endoplasmic reticulum (52). Intracellular localization of HO corresponds to localization of NOS and prostaglandin cyclooxygenase (COX) that may suggest functional cross talk among CO, NO, and prostanoids. In the carotid body, intracellular HO-2 colocalizes with large-conductance Ca2+-activated K+ (BKCa) channels (150). Localization with BKCa channels may be important for cerebral circulatory control because HO-2-derived CO activates BKCa channels to produce vascular smooth muscle relaxation (see Mechanism of CO-induced cerebrovascular dilation, below). In pulmonary artery endothelial cells, HO-1 was detectable in plasma membrane caveolae, where caveolin binds to HO-1 and regulates its enzymatic activity (68). Under certain conditions, HO-1, but not HO-2, is localized to the nucleus in differentiated astroglial cells (85) and pulmonary artery endothelial cells (68), indicating a possibility of nuclear functions of HO-1.

The highest HO-2 expression is found in the brain, cerebral vasculature, and testes (85, 93, 95). Steroid hormones are the only known regulators of HO-2 expression (4, 92, 94, 116, 147). The presence of glucocorticoid response element in the promoter region of the HO-2 gene accounts for upregulation of HO-2 expression (88). High expression in the brain, including selected neuronal populations (29, 33, 34, 57, 158), glia (129), and cerebral vasculature (84, 117), indicates an important role of HO-2 in brain physiological functions that include regulation of cerebral blood flow and mediation of neuronal activity.

Under basal conditions, HO-1 is expressed strongly only in reticuloendothelial cell-rich tissues, such as spleen and liver, where it functions to eliminate potentially toxic heme released from degraded red blood cells (94). In the brain and in cerebral vasculature, no HO-1 expression has been detected under basal conditions (34, 84, 117, 119). HO-1 is an early response gene (heat shock protein 32) that can be induced by a variety of stress factors, including heme, metalloporphyrins, heavy metals, cytokines, oxidative stress, and oxidized lipids (2, 18, 31, 38, 56, 65, 75, 77, 93, 95, 119, 125). Induction of HO-1 is regulated at the level of gene transcription via cell-specific multiple regulatory elements in the promoter region of HO-1 gene, including but not limited to stress response elements and antioxidant response elements in conjunction with the redox-sensitive transcription factor Nrf2 (98, 111), NF-{kappa}B (76), and cAMP-responsive element (75). Enhanced HO-1 gene transcription may also occur via binding of the basic helix-loop-helix-leucine zipper family of transcription factors upstream stimulating factor (USF)1 and USF2 to the class B E-box located in the proximal promoter of the human HO-1 gene (49). In addition, HO-1 protein induction via translation-independent mRNA stabilization has been described (13).

Mechanism of CO-induced cerebrovascular dilation.   It has been proposed that CO-induced cell signaling may be via activation of GC (51, 97). Indeed, treatment of platelets (16) or aorta (41) with CO or a CO-releasing molecule (37), as well as overexpression of HO-1 in pulmonary artery or aorta (3, 107, 127), increase cGMP. CO is much less effective at stimulating GC than is NO (6971), but involvement of an endogenous substance that increases GC sensitivity to CO has been suggested (24, 142). Nevertheless, cGMP as a direct mediator of CO dilation in cerebrovascular circulation under physiological conditions appears unlikely. An increase in cGMP production coincident with CO-induced dilation has not been demonstrated, and normal dose-dependent dilation to CO occurs with cGMP held constant (72, 82). Furthermore, the ability of GC inhibition to attenuate vasodilation to CO (37, 51, 79, 144), in the cerebrovascular circulation at least, can be entirely explained by a role of cGMP as a necessary permissive enabling factor (see below).

In contrast to cGMP, extensive evidence suggests CO-induced dilation is mediated by BKCa channel activation. BKCa channel inhibition blocks CO-induced vasodilation (84, 110, 159). HO inhibitors reduce BKCa channel activity in renal and tail artery smooth muscle cells, suggesting that HO-derived products activate BKCa channels (63, 152). O2 can regulate BKCa channels indirectly via CO, because O2 is necessary for heme metabolism by HO (150). Conversely, inhibitors of soluble GC do not attenuate CO-induced BKCa channel activation in smooth muscle cells isolated from cerebral and renal arteries (63, 153). Furthermore, CO activates BKCa channels in excised arterial smooth muscle cell membrane patches that are removed from the intracellular milieu (150, 152, 153). Chemical modification of histidine residues blocks CO-induced BKCa channel activation, suggesting an important role for this amino acid (147). CO activates BKCa channel {alpha}-subunits expressed in the absence of auxiliary beta-subunits in mammalian cells, suggesting that CO acts on the pore-forming {alpha}-subunit (152, 153). Antisense downregulation of the beta-subunit abolished NO-induced BKCa channel activation but did not alter CO-induced BKCa channel activation in rat tail artery smooth muscle cells, indicating that CO and NO activate BKCa channels by different mechanisms (152). Taken together, these findings show that CO activates BKCa channels by interacting with the {alpha}-subunit or an associated regulatory element.

The {alpha}-subunit of the BKCa channel contains a heme-binding pocket, and binding of heme to the BKCa channel inhibits BKCa channel activity (140). CO, by binding to channel-bound ferrous heme, changes the association of the heme with the channel leading to channel activation (60). Therefore, the BKCa channel is functionally a heme-protein. BKCa channel-bound heme is the receptor for CO, and CO binding increases BKCa channel Ca2+ sensitivity (see next paragraph).

In smooth muscle cells, BKCa channels are activated by local intracellular Ca2+ transients termed "Ca2+ sparks" that elevate the local Ca2+ concentration into the micromolar range (61). A single Ca2+ spark activates several BKCa channels, leading to an outward BKCa transient. In the arterial wall, summation of transient Ca2+-activated K+ currents induces a membrane hyperpolarization that reduces voltage-dependent Ca2+ channel (VDCC) activity and, thus, intracellular Ca2+ concentration. In cerebral artery smooth muscle cells, CO elevates BKCa channel Ca2+ sensitivity, particularly within the micromolar Ca2+ concentration range (153). Accordingly, endogenous HO-derived CO and exogenous CO elevate BKCa channel-transient frequency and amplitude by enhancing the effective coupling of Ca2+ sparks to BKCa channels (59). CO also elevates Ca2+ spark frequency that contributes to the CO-induced transient Ca2+-activated K+ current frequency and amplitude elevation. Because inhibitors of Ca2+ sparks and BKCa channels block CO-induced cerebrovascular dilation in vivo, Ca2+ spark to BKCa channel coupling is essential for vasodilatory actions of CO (59, 84).

In the piglet cerebrovascular circulation, CO interacts with two other prominent endothelium produced vasodilators. Inhibition of either NOS or COX blocks dilation to CO (83). However, these blockades are not the consequence of CO increasing NO and prostacyclin that cause the dilation. The contributions of NO and prostacyclin are permissive in that only sufficient background levels are necessary before CO will produce dilation of piglet cerebral arterioles. Thus, if the concentration of NO and/or prostacyclin is held constant by blocking synthesis, but providing exogenous NO and/or prostacyclin, CO produces dose-dependent pial arteriolar dilation that is indistinguishable from the responses when NOS and COX are not inhibited (83). Furthermore, the final mechanism behind the permissive actions of NO and prostacyclin appears to be the same because either the prostacyclin mimics iloprost or the NO-generating molecule sodium nitroprusside (SNP) can return dilation to CO when both COX and NOS are inhibited (82). The source of the permissive mediators may be endothelial because endothelial denudation blocks CO-induced dilation and SNP or 8-br-cGMP restores dilation to CO (8). The actions of both NO and prostacyclin are mediated by protein kinase G, but only the NO action is via cGMP (82). Whether the action of protein kinase G is on the BKCa channel, ryanodine receptor, both, or another mechanism has not as yet been determined.

Functional significance of CO in control of cerebrovascular circulation.   Functional significance of purported messengers and processes is usually suggested by actions of pharmacological inhibitors. Pharmacological inhibition of HO with substituted metalloporphyrins is a major source of data on the functional significance of endogenous CO, in addition to measurements of CO production, overexpression of endogenous HO, and application of exogenous CO and CO-releasing molecules.

Available data suggest that the predominant effects of HO inhibitory metalloporphyrins on cerebrovascular circulation in vivo result from HO inhibition. For example, photooxidized porphyrins do not block HO (42), and photooxidized chromium mesoporphyrin (CrMP) does not alter cerebrovascular responses (123). Furthermore, copper mesoporphyrin, a metal porphyrin that does not inhibit HO, does not affect dilatory responses to {alpha}-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propionic acid, or 1-amino-1,3-cyclo-pentanedicarboxylic acid (123).

Actions of metalloporphyrins unrelated to HO inhibition have been reported. Micromolar concentrations of metal porphyrins can both inhibit (55, 131) and activate GC (131). However, tin protoporphyrin (SnPP) does not affect dilation to SNP, a cGMP-dependent dilator (12). In hippocampal slices, effects of CrMP and zinc protoporphyrin (ZnPP) on NOS activity were greater than those of tin mesoporphyrin and zinc deuteroporphyrin, even though all inhibited HO (102). These data suggest CrMP and ZnPP might inhibit NOS independently of HO inhibition. Conversely, ZnPP stimulated NO production by rabbit internal anal sphincter, an action apparently related to HO inhibition (19). ZnPP, but not other protoporphyrins, may inhibit VDCC in pituitary cells (87). However, the consequence of inhibition of VDCC would be dilation, not constriction, so involvement of inhibition of VDCC in metalloporphyrin blockade of putative CO-dependent responses in cerebrovascular circulation is unlikely. Metalloporphyrin inhibition of G protein coupling to second-messenger systems has been reported (112, 143). However, in piglet cerebral circulation metalloporphyrins do not inhibit dilation to isoproterenol, suggesting no interference with G protein function (84). Finally, inhibitory activity toward another necessary component of heme metabolism, NADPH-cytochrome P-450 reductase, and possible effects on the expression as well as activity of HO-2 in rat brain have been reported for SnPP, but not for ZnPP (96).

Alternative strategies to pharmacological inhibitors have limitations as well. Antisense oligonucleotide approaches suffer from cell toxicity and ineffectiveness (25, 26, 128), and siRNA, which can be more efficient than antisense oligonucleotides, also can have unintended actions (48, 126, 128). Loss of specific functions in knockout mice without genes of interest can be very convincing, but no in vivo data are available for HO in cerebrovascular circulation. Also, this approach can be limited by biological compensation for missing proteins and questions of removal of processes and pathways associated with the intended target during development.

Overall, pharmacological inhibition of enzymes and receptors remains the most rapid and effective approach for removal of messages and processes of interest. Although there are potential non-HO-mediated actions of metalloporphyrin HO inhibitors, none appear to account for the actions of these compounds on cerebrovascular circulation.

CO is a gasotransmitter related to neural function in the brain (10). Neurally released CO could be a regulator of cerebral blood flow, but no data supporting this concept have been collected to date. In vivo, topical CO (nM) dilates pial arterioles (84). Brain production of CO results in accumulation in cerebrospinal fluid (CSF) placed under cranial windows that is contiguous with brain extracellular fluid. Dilator concentrations of CO in this CSF (88 ± 20 nM) have been measured under control conditions, and 10-fold increases have been measured with strong stimulation (12). Thus the level of CO production by brain and vessels is sufficient to provide dilator effects on the cerebral circulation.

Indications of functional significance of CO are further supported by alterations of responses to important physiological cerebrovascular regulatory stimuli upon inhibition of HO with substituted metalloporphyrins. Pial arteriolar dilations to both hypoxia and topical glutamate are selectively inhibited after topical treatment with CrMP that blocks CO production (84, 123). Furthermore, CO appears to be involved in pial arteriolar dilation to hypotension (64). Mediation of autoregulatory vasodilation could contribute to the protective effects of HO after brain ischemia, but most evidence suggests that the antioxidant properties of bilirubin are largely responsible (71). CO can also attenuate vascular responses to constrictor stimuli (151). For example, inhibition of HO accentuates the constriction of pial arterioles produced by hypertension but has minimal effects when piglets are normotensive. In addition, vasoconstriction to topical application of platelet activating factor is accentuated after inhibition of HO. In rat hypothalamus, CO has been shown to contribute to regulation of vascular tone that is particularly evident in the absence of NO (50). This finding in adult rats appears to be different from results of newborn pigs where NO plays an obligatory permissive role in CO-induced dilation and NOS inhibition blocks dilation to CO (see Mechanism of CO-induced cerebrovascular dilation, above).

Although reported actions of CO on cerebrovascular tone are uniformly dilating, it should be mentioned that in skeletal muscle vasculature CO has been shown to be capable of producing vasoconstriction, apparently by inhibiting NOS. Thus, in isolated, pressurized, phenylephrine-treated rat gracilis muscle arterioles, either exogenous CO or stimulation of endogenous CO production produced constriction that was prevented by endothelium removal (40). That this constriction involves reduction of endothelial-derived NO is indicated by the ability of L-arginine to prevent the constriction and of NOS inhibition to convert the CO-induced constriction to dilation. Of interest, results from rat gracilis muscle arterioles are opposite of those from small rat renal arteries where CO increased NO production that contributed to CO-induced dilation (140).

Protective effects of HO-CO and regulation of CBF during seizures.   CO produced by the brain contributes to regulation of cerebral blood flow during seizures (17, 105, 122). In bicuculline-induced epileptic seizures in newborn pigs, pial arteriolar dilation that occurs simultaneously with neuronal activation correlated with a massive increase in CO concentration in cortical CSF that was sustained for the duration of seizures (17, 115). HO inhibitors CrMP and SnPP inhibited CO production by the brain and reduced cerebral dilation in response to seizures (17, 115, 122). The rapid increase in CO production by the brain during epileptic seizures is attributable exclusively to constitutive HO-2, because no induction of HO-1 or HO-2 protein was observed (17, 119). The rapid increase in HO-2 enzymatic activity in the cerebral vasculature occurs via a glutamate receptor-mediated mechanism.

The major excitatory neurotransmitter, glutamate, is massively released from neurons during seizures (103). Cerebral microvascular endothelial cells from rat, human, and pig, in addition to neurons and glia, have receptors for glutamate (14, 23, 74, 116, 133, 134). Both ionotropic and metabotropic subtypes have been identified in cerebral vascular endothelial cells (23, 116, 133, 134). Conversely, other investigators were unable to detect glutamate receptors on cerebral microvascular endothelial cells from sheep, rat, or human (9, 108). The reason for these opposing results is not apparent. Consistent with the presence of receptors, glutamate receptor agonists cause functional responses in cerebral vascular endothelial cells that include increases in HO activity (116), changes in endothelial monolayer permeability (134), and increases in formation of ROS (14, 134). Of significance to the present review, piglet cerebral microvessels respond directly to glutamate and selective N-methyl-D-aspartic acid (NMDA) and {alpha}-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/kainate receptor agonists by increasing CO production (79, 116). We found pressurized pial arteries respond to glutamate by endothelium-dependent vasodilation (11% at 10–5 M) (36), although less strongly than in vivo (20% dilation at 10–5 M) (123). Others have failed to detect any glutamate-receptor-mediated responses in pressurized bovine middle cerebral arteries (149) or middle cerebral arteries from newborn pigs (135). Although the difference in species, age, and artery examined could account for divergent results in the first instance, the reason for the inconsistent results in piglets is not evident. The choice of anesthetic, ketamine vs. pentobarbital, is different but appears to be an unlikely contributor in an isolated vessel experiment. Although the diameters of the vessels in the two studies are similar, the arteries selected may not be the same, because Simandle et al. (135) could pressurize to 100 mmHg, which was not tolerated by arteries used by Fiumana et al. (36). Heterogeneity of responses even in pial arteries and arterioles within a 1-cm-diameter circle of surface parietal cortex has been described (118). Regardless, it is clear that cerebral arterioles respond more strongly to glutamate in vivo than in vitro, suggesting extravascular cells contribute to glutamatergic dilation.

Epileptic seizures result in prolonged postictal cerebral vascular dysfunction characterized by reduced vasoreactivity to physiologically relevant dilators, including hypercapnia and bradykinin (119). When HO-2 activity is inhibited before seizures, cerebral vascular dysfunction is observed immediately after the ictal episode and is extended for at least 2 days of the postictal period (17, 119). In contrast, in animals with intact HO-2 activity, no immediate reduction of cerebral vascular reactivity is detected, but cerebral vascular reactivity is greatly reduced 2 days later (12, 86). Therefore, HO-2 is necessary for a short-term protection but not sufficient for long-term protection of the cerebral vasculature from detrimental effects of epileptic seizures. However, upregulation of cerebral HO-1 expression can completely protect the cerebral vasculature during the delayed postictal period (119). Thus it appears that HO-1 can provide long-term protection against postictal cerebral vascular dysfunction. HO-derived CO is important in increasing blood flow to the brain to match excessive neuronal activity during the ictal episode, thus protecting neurons and preventing cerebral vascular injury. HO activity also reduces the amount of prooxidant heme and results in production of biliverdin and bilirubin, which have powerful antioxidant properties as a redox cycling pair that scavenges ROS (7, 29, 95, 104). Also, CO itself may have antiapoptotic effects in vascular endothelial and smooth muscle cells.

CO, apoptosis, and cell proliferation.   In addition to its role as a neuronal and vascular messenger, CO can suppress apoptosis (15, 136, 160). The molecular mechanism of antiapoptotic protection by CO is not clear. CO may inhibit generation of free radicals by mitochondria via a direct interaction with the heme protein of the mitochondrial electron transport chain, or interact with the p38 MAPK- or cGMP-signaling pathways that can modulate apoptosis in a cell- and signal-specific manner (136). In addition, CO inhibits the activity of caspases that play a major role in executing apoptosis (138, 160). A possible interaction of CO with NF-{kappa}B-mediated apoptosis signaling also has been proposed (15, 90, 136). Proapoptotic effects of CO have also been reported (139). It appears that the ability of CO to suppress or promote apoptosis depends on the specific apoptotic signal and cell type.

In addition to effects on apoptosis, CO may affect cerebrovascular circulation via regulation of vascular cell proliferation. In rat aortic smooth muscle cells, increasing CO inhibited and scavenging CO increased cell proliferation, actions apparently mediated by increasing cGMP that increases E2F-1 expression (106). Furthermore, CO can reduce endothelial cell proliferation caused by hypoxia by inhibiting VEGF production by adjacent vascular smooth muscle (91). This action as well appears to be mediated via cGMP, by decreasing binding of a hypoxic enhancer to hypoxia-inducible factor-1. After vascular injury as well as hypoxia, CO suppresses vascular smooth muscle proliferation by increasing cellular cGMP that activates p38 mitogen-activated protein kinase, upregulating caveolin-1 that prevents proliferation (69). Conversely, CO has been shown to promote proliferation of microvascular endothelial cells (86). Thus, depending on the conditions, background stimuli, and specific cell type, CO can either increase or decrease apoptosis and cell proliferation.


    HYDROGEN SULFIDE
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The following discussion is summarized pictorially in Fig. 2.


Figure 2
View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2. Flow chart summarizing the section of this review on hydrogen sulfide (H2S). CSE, cystathione {gamma}-lyase.

 
Control of H2S production.   Production and utilization of H2S have been demonstrated in tissues from different life forms, including bacteria and archae (113), nonmammalian vertebrates (28), and mammals (145, 146) with physiological concentrations in the range of 20–160 µM (1, 163).

Two pyridoxal-5'-phosphate-dependent enzymes, cystathionine beta-synthase (CBS) and cystathionine {gamma}-lyase (CSE), are responsible for the endogenous production of H2S in mammalian tissues (1, 145, 146, 163). Although expression of CBS is more abundant in liver and neuronal tissues, CSE is the dominant H2S-generating enzyme in the cardiovascular system. CSE and CBS catalyze the hydrolysis of cysteine via beta-elimination to generate H2S. A beta-replacement reaction in which cysteine is condensed in the presence of CSE with homocysteine to form cystathionine and H2S has been recently reported in vitro (21). The condensation of cysteine is believed to be 50 times more efficient than hydrolysis of cysteine in terms of H2S production (21).

The synthetic pathway for H2S production is intermingled with the synthetic pathway for NO. The expression and activity of CSE are upregulated by NO, but hydroxylamine (a precursor of NO) inhibits the activity of CBS (114). S-adenosylmethionine and pyridoxal-5'-phosphate stimulate CSE activity to increase H2S production (70, 132). Kimura (70) reported that CBS-mediated hydrolysis of cysteine was regulated by Ca2+ and CaM in mouse brain. This observation, however, could not be repeated by Chen et al. (21) in mouse brain, mouse liver, or purified recombinant human CBS expressed in E. coli or yeast.

Mechanism of H2S vascular actions.   Compelling evidence indicates that ATP-sensitive K+ (KATP) channels are major targets of H2S. Opening of KATP channels hyperpolarizes cells and closes VDCC. This provides an important mechanism linking cellular metabolism to excitability and contractility of vascular smooth muscle cells. Patch-clamp studies show that H2S increases whole cell KATP channel currents in single smooth muscle cells isolated from both aorta and mesenteric arteries (22, 163). This stimulatory effect of H2S is concentration dependent and reversible. The KATP inhibitor glibenclamide blocks and the activator pinacidil mimics the effect of H2S on KATP channels. H2S hyperpolarizes smooth muscle cells, and the action is antagonized by glibenclamide (163). The molecular mechanisms underlying the effect of H2S on KATP channels are still largely unknown. Alteration of intracellular ATP concentration cannot explain the interaction between H2S and KATP channels because clamping intracellular ATP at different levels did not alter the relative stimulatory effect of H2S on the whole cell KATP channels (163). Because H2S is a reductant (68), it is possible that H2S directly interacts with KATP channel proteins by reducing the cysteine residues. A mutagenesis approach that replaces cysteine residues with structurally similar serine residues would support this hypothesis if H2S fails to stimulate KATP channels after selective point mutation of cysteine residues.

The proapoptotic effect of H2S is related to increased activity of extracellular signal-regulated kinase (ERK), but not p38 MAPK or c-Jun NH4-terminal kinase activity. Activation of caspase-3 by ERK could be one downstream target of H2S-ERK interaction (154).

Functional significance of H2S in circulatory regulation.   Vascular contractility is regulated by endogenous and exogenous H2S at physiologically relevant concentrations. Intravenous injection of H2S decreases mean arterial blood pressure of anesthetized rats by decreasing vascular resistance (163). Daily intraperitoneal injections of D,L-propargylglycine (PPG), a specific blocker of CSE, for 2–3 wk elevates systolic blood pressure (162). Because this PPG treatment suppresses H2S production in vascular and other tissues, PPG-induced hypertension may result from reduced endogenous H2S production in vascular tissues (162). H2S concentration-dependently relaxes phenylephrine-precontracted rat aorta, a conduit artery (161). The isolated and perfused rat mesenteric vascular bed, a model of peripheral resistance arteries, is also relaxed by H2S (16). Although rat aortic and mesenteric artery tissues generate comparable levels of H2S (15, 161163), rat mesenteric arteries are much more sensitive to H2S (EC50 of 25.2 ± 3.6 µM) than rat aorta (EC50 of 125 ± 14 µM). L-Cysteine, a substrate of CSE and CBS, increases endogenous H2S production and decreases contractility of mesenteric arteries. In contrast, PPG abolishes the L-cysteine-dependent increase in H2S production and relaxation of mesenteric arteries. These findings indicate the importance of endogenous H2S in regulating vascular contractility (22).

H2S can be involved in the control of both proliferation and apoptosis in vascular smooth muscle cells. H2S at physiologically relevant concentrations did not induce necrosis of human aortic smooth muscle cells (154). However, H2S (200–500 µM) increased the numbers of condensed apoptotic nuclei, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive cells, and oligonucleosomal DNA fragmentation. The cells showed the morphological changes typical of apoptosis within 2 h of H2S application. Interestingly, baseline endogenous H2S modulates exogenous H2S-induced apoptosis of human aortic smooth muscle cells. Treatment of these cells with the CSE inhibitor PPG alone for 1 h did not induce any apoptotic changes. This preconditioning treatment, however, significantly enhanced the proapoptotic effect of exogenously applied H2S. The threshold concentration of H2S to induce apoptosis was reduced from 200 to 100 µM under this condition. It is hypothesized that basal endogenous H2S may be high enough to desensitize apoptotic signaling pathways in vascular smooth muscle cells. As such, the basal H2S level may serve as a set point for the basal apoptotic status of smooth muscle cells. Increases or decreases in endogenous H2S levels may consequently alter homeostatic control of smooth muscle cell apoptosis.

H2S also can inhibit cell proliferation. Stable overexpression of CSE in HEK-293 cells increased endogenous H2S production and inhibited cell proliferation and DNA synthesis (154). These effects were significantly reversed in the presence of the H2S scavenger, methemoglobin. Exogenous H2S at the physiologically relevant concentration of 100 µM also inhibited cell proliferation. However, neither overexpression of CSE nor application of exogenous H2S induced apoptosis of HEK-293 cells. The difference between the endogenous H2S basal levels in vascular smooth muscle cells and HEK-293 cells may underlie the lack of proapoptotic response of HEK-293 cells to H2S. It has been reported that CSE expression level and its enzymatic activity were higher in kidney (HEK) than in smooth muscle (58).

The function of H2S in cerebral circulation remains poorly understood. H2S is produced in brain tissues, reaching an endogenous level of 50–160 µM (1). The release of corticotropin-releasing hormone from hypothalamus and facilitation of hippocampal long-term potentiation appear to be influenced by H2S metabolism (70). Environmental exposure to H2S at low concentrations for 2 wk activates protein synthesis in nerve cells and myelinated fibers in the cerebral cortex (137), but the physiological meaning of this study is unclear. It appears likely that endogenously produced H2S exerts similar vasorelaxant effects on the cerebral circulation as in the systemic circulation. Cerebral vascular smooth muscle cells would be exposed to significant amounts of H2S, and cerebral vascular smooth muscle cells possess the KATP channels (144), the target of H2S on other vascular smooth muscle cells (145). A recent study showed that NMDA-induced dilation of pial arteries in newborn pigs was partially due to activation of KATP channels (121). In glutamatergic neurons, endogenous H2S has been shown to enhance NMDA receptor-mediated transmembrane currents (70).


    CONCLUSIONS
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
CO and H2S are gaseous cellular messenger molecules that are involved in cerebrovascular flow regulation. Thus they join the group with the most studied gaseous mediator, NO. The collective differences between the gasotransmitters and the classical neurotransmitters, hormones, and lipid and peptide autocrine/paracrine messengers in intercellular movement, cellular action mechanisms, and signal termination are already revolutionizing our concepts of cellular communication. This review has focused on two of these molecules, CO and H2S, the physiological significance of which have begun to be appreciated in the last decade or less.

CO exerts a dilator influence on the cerebral circulation and is involved in active hyperemia, autoregulation, hypoxic dilation, and counteracting vasoconstriction. CO is produced by metabolism of cellular heme by a constitutive enzyme expressed highly in the cerebral microcirculation and by an inducible enzyme that is readily upregulated in brain by potentially injurious conditions. CO production is regulated by controlling substrate, HO-2 catalytic activity, and HO-1 expression. CO causes cerebrovascular dilation by elevating smooth muscle BKCa channel Ca2+ sensitivity, leading to increased coupling to Ca2+ sparks, thereby hyperpolarizing the cell. The HO-CO vasodilatory system interacts at both the level of messenger production and action with other important mediators of cerebral circulatory control, including NO and prostanoids. Although much is becoming known, much more remains unknown about CO and cerebrovascular circulatory control. Even though CO is involved in several cerebral circulatory control mechanisms, many other situations in which CO may be a key mediator remain to be explored, and very little is known about pathological alterations of HO-CO system in the cerebral circulation. The cellular origins of CO mediating distinct responses in the intact cerebral circulation are largely unknown. Knowledge of the mechanisms regulating CO production is only beginning to become available, and those data appear to contrast at times. Although mechanisms by which CO can affect the activity of BKCa channels are being revealed, these mechanisms are still not completely understood. In addition, CO can contribute to vascular remodeling by enhancing or depressing both apoptosis and cellular proliferation, depending on cell type and particularly other impinging signals. Thus much of the physiology and biochemistry of HO-CO in the cerebral circulation remains open for exploration.

H2S is a very recently identified gasotransmitter that is produced by many mammalian cells, including vascular smooth muscle cells. By relaxing vascular smooth muscle cells to dilate blood vessels, promoting apoptosis of vascular smooth muscle cells, and inhibiting proliferation-associated vascular remodeling, H2S modulates both the function and structure of the circulatory system. The mechanisms behind H2S-induced activations of KATP channels on the cell membrane and the ERK signaling pathway inside cells are not yet understood. Genetic approaches to manipulate CSE expression and endogenous production of H2S may help to decisively establish physiological and pathophysiological importance of H2S in regulation of cerebrovascular tone in particular and cardiovascular function in general. Future studies should examine vasorelaxant and proapoptotic, antiproliferative effects of H2S on cerebral vascular tissues. Advancing in this understanding also has the potential to provide novel therapeutic avenues for treatment of many vascular diseases linked to H2S-related abnormal cellular contractility and proliferation.


    GRANTS
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
C. W. Leffler, J. H. Jaggar, and H. Parfenova are supported by the National Heart, Lung, and Blood Institute. H. Parfenova is also supported by the National Institute of Neurological Disorders and Stroke. R. Wang is supported by the Canadian Institutes of Health Research.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank G. Short for construction of the figures and M. Lester for clerical assistance.


    FOOTNOTES
 

Address for reprint requests and other correspondence: C. W. Leffler, Dept. of Physiology, 894 Union Ave., Memphis, TN 38163 (e-mail: cleffler{at}physio1.utmem.edu)


    REFERENCES
 TOP
 ABSTRACT
 CARBON MONOXIDE
 HYDROGEN SULFIDE
 CONCLUSIONS
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Abe K and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066–1071, 1996.[Abstract/Free Full Text]
  2. Abraham NG, Botros FT, Rezzani R, Rodella L, Bianchi R, and Goodman AI. Differential effect of cobalt protoporphyrin on distributions of heme oxygenase in renal structure and on blood pressure in SHR. Cell Mol Biol (Noisy-le-grand) 48: 895–902, 2002.[Medline]
  3. Abraham NG, Quan S, Mieyal PA, Yang L, Burke-Wolin T, Mingone CJ, Goodman AI, Nasjletti A, Wolin MS. Modulation of cGMP by human HO-1 retrovirus gene transfer in pulmonary microvessel endothelial cells. Am J Physiol Lung Cell Mol Physiol 283: L1117–L1124, 2002.[Abstract/Free Full Text]
  4. Acevedo CH and Ahmed A. Heme oxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J Clin Invest 101: 949–955, 1998.[Web of Science][Medline]
  5. Appleton SD, Marks GS, Nakatsu K, Brien JF, Smith GN, and Graham CH. Heme oxygenase activity in placenta: direct dependence on oxygen availability. Am J Physiol Heart Circ Physiol 282: H2055–H2059, 2002.[Abstract/Free Full Text]
  6. Baram TZ and Snead OC. Bicuculline-induced seizures in infant rats: ontogeny of behavioral and electrocortical phenomena. Dev Brain Res 57: 291–295, 1990.[Medline]
  7. Baranano DE and Snyder SH. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 98: 10996–11002, 2001.[Abstract/Free Full Text]
  8. Barkoudah E, Jaggar JH, and Leffler CW. The permissive role of endothelial NO in CO-induced cerebrovascular dilation. Am J Physiol Heart Circ Physiol 287: H1459–H1465, 2004.[Abstract/Free Full Text]
  9. Beart PM, Sheehan KA, and Manallack DT. Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels. J Cereb Blood Flow Metab 8: 879–821, 1988.[Web of Science][Medline]
  10. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, and Snyder SS. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40: 129–137, 2003.[CrossRef][Web of Science][Medline]
  11. Boehning D, Sedaghat L, Sedlak TW, and Snyder SH. Heme oxygenase-2 is activated by calcium-calmodulin. J Biol Chem 279: 30927–30930, 2004.[Abstract/Free Full Text]
  12. Boehning D and Snyder SH. Novel neural modulators. Annu Rev Neurosci 26: 105–131, 2003.[CrossRef][Web of Science][Medline]
  13. Bouton C and Demple B. Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide. J Biol Chem 275: 32688–93263, 2000.[Abstract/Free Full Text]
  14. Bresgen N, Karlhuber G, Krizbai I, Bauer H, Bauer HC, and Eckl PM. Oxidative stress in cultured cerebral endothelial cells induced chromosomal aberrations, micronuclei, and apoptosis. J Neurosci Res 72: 327–333, 2003.[CrossRef][Web of Science][Medline]
  15. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015–1026, 2000.[Abstract/Free Full Text]
  16. Brune B and Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32: 497–504, 1987.[Abstract]
  17. Carratu P, Pourcyrous M, Fedinec A, Leffler CW, and Parfenova H. Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. Am J Physiol Heart Circ Physiol 285: H1148–H1157, 2003.[Abstract/Free Full Text]
  18. Caudill TK, Resta TC, Kanagy NL, and Walker BR. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia. Am J Physiol Regul Integr Comp Physiol 275: R1025–R1030, 1998.[Abstract/Free Full Text]
  19. Chakder S, Rathi S, Ma XL, and Rattan S. Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. J Pharmacol Exp Ther 277: 1376–1382, 1996.[Abstract/Free Full Text]
  20. Chang EF, Wong RJ, Vreman HJ, Igarashi T, Galo E, Sharp F, Stevenson DK, and Noble-Haeusslein LJ. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241–250, 2004.[CrossRef][Web of Science][Medline]
  21. Chen X, Jhee KH, and Kruger WD. Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem 279: 52082–52086, 2004.[Abstract/Free Full Text]
  22. Cheng Y, Ndisang JF, Tang G, Cao K, and Wang R. Sensitive relaxant response of rat mesenteric artery beds to hydrogen sulfide. Am J Physiol Heart Circ Physiol 287: H2316–H2323, 2004.[Abstract/Free Full Text]
  23. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, and Colgan SP. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277: 14801–14811, 2002.[Abstract/Free Full Text]
  24. Colpaert EE, Timmermans JP, and Lefebvre RA. Investigation of the potential modulatory effect of biliverdin, carbon monoxide and bilirubin on nitrergic neurotransmission in the pig gastric fundanus. Eur J Pharmacol 457: 177–186, 2002.[CrossRef][Web of Science][Medline]
  25. Crooke ST and Bennett CF. Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 36: 107–129, 1996.[CrossRef][Web of Science][Medline]
  26. Crooke ST. Antisense strategies. Curr Mol Med 4: 465–487, 2004.[CrossRef][Web of Science][Medline]
  27. Ding Y, McCoubrey WK Jr, and Maines MD. Interaction of heme oxygenase-2 with nitric oxide donors. Is the oxygenase an intracellular ‘sink' for NO? Eur J Biochem 264: 854–861, 1999.[Web of Science][Medline]
  28. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, and Olson KR. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288: R243–R252, 2005.[Abstract/Free Full Text]
  29. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, and Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 96: 2445–2450, 1999.[Abstract/Free Full Text]
  30. Drummond GS, Greenbaum NL, and Kappas A. Tin(Sn+4)-diiododeuteroporphyrin; an in vitro and in vivo inhibitor of heme oxygenase with substantially reduced photoactive properties. J Pharmacol Exp Ther 257: 1109–1113, 1991.[Abstract/Free Full Text]
  31. Dwyer BE, Nishimura RN, and Lu SY. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 30: 37–47, 1995.[Medline]
  32. Ellis A and Tiggle CR. Endothelium-derived activated oxygen species: their relationship to endothelial-dependent hyperpolarization and vascular tone. Can J Physiol Pharmacol 81: 1013–1028, 2003.[CrossRef][Web of Science][Medline]
  33. Ewing JF and Maines MD. In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: differential distribution of isozyme 1 and 2. Mol Cell Neurosci 3: 559–570, 1992.[CrossRef][Web of Science]
  34. Ewing JF, Weber CM, and Maines MD. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J Neurochem 61: 1015–1023, 1993.[CrossRef][Web of Science][Medline]
  35. Faraci FM and Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53–97, 1998.[Abstract/Free Full Text]
  36. Fiumana E, Parfenova H, Jaggar JH, and Leffler CW. Carbon monoxide mediates vasodilator effects of glutamate in isolated pressurized cerebral arterioles of newborn pigs. Am J Physiol Heart Circ Physiol 284: H1073–H1079, 2003.[Abstract/Free Full Text]
  37. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, and Motterlini R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142: 453–460, 2004.[CrossRef][Web of Science][Medline]
  38. Foresti R, Sarathchandra P, Clark JE, Green CJ, and Motterlini R. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis. Biochem J 339: 729–736, 1999.[CrossRef][Web of Science][Medline]
  39. Friebe A, Schultz G, and Koesling D. Sensitizing soluble guanylate cyclase to become a highly CO-sensitive enzyme. EMBO J 15: 6863–6868, 1996.[Web of Science][Medline]
  40. Fruzsina K and Johnson RA. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 285: R536–R541, 2003.[Abstract/Free Full Text]
  41. Furchgott RF and Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28: 52–61, 1991.[Web of Science][Medline]
  42. Greenbaum NL and Kappas A. Comparative photoactivity of tin and zinc porphyrin inhibitors heme oxygenase: pronounced photolability of the zinc compounds. Photochem Photobiol 54: 183–192, 1991.[Web of Science][Medline]
  43. Grundemar L and Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18: 193–195, 1997.[Medline]
  44. Gutterman DD, Miura H, and Liu Y. Redox modulation of vascular tone. Focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25: 671–678, 2005.[Abstract/Free Full Text]
  45. Haeusslein LJ. Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci 23: 3689–3966, 2003.[Abstract/Free Full Text]
  46. Harder DR, Zhang C, and Gebremedhin D. Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci 16: 27–31, 2002.
  47. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, and Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241–250, 2004.[CrossRef][Web of Science][Medline]
  48. Heidenreich O. Oncogene suppression by small interfering RNAs. Curr Pharm Biotechnol 5: 349–354, 2004.[CrossRef][Web of Science][Medline]
  49. Hock TD, Nick HS, and Agarwal A. Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription. Biochem J 383: 209–218, 2004.[CrossRef][Web of Science][Medline]
  50. Horvath B, Hrabak A, Kaldi K, Sandor P, and Benyo Z. Contribution of the heme oxygenase pathway to the maintenance of the hypothalamic blood flow during diminished nitric oxide synthesis. J Cereb Blood Flow Metab 23: 653–657, 2003.[Web of Science][Medline]
  51. Hosein S, Marks GS, Brien JF, McGlaughlin BE, and Nakatsu K. An extracellular source of heme can induce a significant heme oxygenase mediated relaxation in the rat aorta. Can J Physiol Pharmacol 80: 761–765, 2002.[CrossRef][Web of Science][Medline]
  52. Hu Y, Ma N, Yang M, and Semba R. Expression and distribution of heme oxygenase-2 mRNA and protein in rat kidney. J Histochem Cytochem 46: 249–256, 1998.[Abstract/Free Full Text]
  53. Huang TJ, McCoubrey WK Jr, and Maines MD. Heme oxygenase-2 interaction with metalloporphyrins: function of heme regulatory motifs. Antioxid Redox Signal 3: 685–696, 2001.[CrossRef][Web of Science][Medline]
  54. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5: 347–360, 2004.[CrossRef][Web of Science][Medline]
  55. Ignarro LJ, Ballot B, and Wood KS. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 259: 6201–6207, 1984.[Abstract/Free Full Text]
  56. Immenschuh S and Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 60: 1121–1128, 2000.[CrossRef][Web of Science][Medline]
  57. Ingi T, Chiang G, and Ronnett GV. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 16: 5621–5628, 1996.[Abstract/Free Full Text]
  58. Ishii I, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, and Kimura H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J 381: 113–123, 2004.[CrossRef][Web of Science][Medline]
  59. Jaggar JH, Leffler CW, Cheranov SY, Tcheranova D, Shuyu E, and Cheng X. Carbon monoxide dilates cerebral arterioles by enhancing the coupling of Ca2+ sparks to Ca2+-activated K+ channels. Circ Res 91: 610–617, 2002.[Abstract/Free Full Text]
  60. Jaggar JH, Li A, Parfenova H, Liu J, Umstot ES, Dopico AM, and Leffler CW. Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K+ channels. Circ Res 97: 805–812, 2005.[Abstract/Free Full Text]
  61. Jaggar JH, Porter VA, Lederer WJ, and Nelson MT. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278: C235–C256, 2000.[Abstract/Free Full Text]
  62. Juckett M, Zheng Y, Yuan H, Pastor T, Antholine W, Weber M, and Vercellotti G. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J Biol Chem 273: 23388–23397, 1998.[Abstract/Free Full Text]
  63. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, and Nasjletti A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107: 1163–1171, 2001.[Web of Science][Medline]
  64. Kanu A, Whitfield J, and Leffler CW. Carbon monoxide contributes to cerebrovascular vasodilation in hypotensive piglets (Abstract). FASEB J 19: A1249, 2005.
  65. Kietzmann T, Samoylenko A, and Immenschuh S. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem 278: 17927–17936, 2003.[Abstract/Free Full Text]
  66. Kikuchi G and Hayashi N. Regulation by heme of synthesis and intracellular translocation of delta-aminolevinulinate synthase in the liver. Mol Cell Biochem 37: 27–41, 1981.[CrossRef][Web of Science][Medline]
  67. Kim C, Zhou Q, Deng B, Thornton EC, and Xu H. Chromium (VI) reduction by hydrogen sulfide in aqueous media: stoichiometry and kinetics. Environ Sci Technol 35: 2219–2225, 2001.[Medline]
  68. Kim HP, Wang X, Galbiati F, Ryter SW, and Choi AMK. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 18: 1080–1089, 2004.[Abstract/Free Full Text]
  69. Kim HP, Wang X, Nakao A, Kim SI, Murase N, Choi ME, Ryter SW, and Choi AM. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc Natl Acad Sci USA 102: 11319–11324, 2005.[Abstract/Free Full Text]
  70. Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13–19, 2002.[CrossRef][Web of Science][Medline]
  71. Koehler R and Traystman RJ. Cerebrovascular effects of carbon monoxide. Antioxid Redox Signal 4: 279–290, 2002.[CrossRef][Web of Science][Medline]
  72. Koneru P and Leffler CW. Role of cyclic GMP in carbon monoxide-induced vasodilation in piglets. Am J Physiol Heart Circ Physiol 286: H304–H309, 2004.[Abstract/Free Full Text]
  73. Kourembanas S, Morita T, Liu Y, and Christou H. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int 51: 438–443, 1997.[Web of Science][Medline]
  74. Krizbai IA, Deli MA, Pestenacz A, Siklos L, Szabo CA, Andras I, and Joo F. Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54: 814–819, 1998.[CrossRef][Web of Science][Medline]
  75. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, and Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 278: 51006–51014, 2003.[Abstract/Free Full Text]
  76. Lavrovsky Y, Schwartzman ML, and Abraham NG. Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem Biophys Res Commun 196: 336–341, 1993.[CrossRef][Web of Science][Medline]
  77. Lee PJ, Hiang B, Chin B, Iyer N, Alam J, Semenza G, and Choi A. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase gene in response to hypoxia. J Biol Chem 272: 5373–5381, 1997.
  78. Lee TJ. Nitric oxide and the cerebral vascular function. J Biomed Sci 7: 16–26, 2000.[CrossRef][Web of Science][Medline]
  79. Leffler CW, Balabanova L, Fedinec AL, Waters CM, and Parfenova H. Mechanism of glutamate stimulation of CO production in cerebral microvessels. Am J Physiol Heart Circ Physiol 285: H74–H80, 2003.[Abstract/Free Full Text]
  80. Leffler CW, Balabanova L, Fedinec AL, and Parfenova H. Nitric oxide increases carbon monoxide production by piglet cerebral microvessels. Am J Physiol Heart Circ Physiol 289: H1442–H1447, 2005.[Abstract/Free Full Text]
  81. Leffler CW, Balabanova L, Sullivan CD, Wang X, Fedinec AL, and Parfenova H. Regulation of CO production in cerebral microvessels of newborn pigs. Am J Physiol Heart Circ Physiol 285: H292–H297, 2003.[Abstract/Free Full Text]
  82. Leffler CW, Fedinec AL, Parfenova H, and Jaggar JH. Permissive contributions of NO and prostacyclin in CO-induced cerebrovascular dilation in piglets. Am J Physiol Heart Circ Physiol 289: H432–H438, 2005.[Abstract/Free Full Text]
  83. Leffler CW, Nasjletti A, Johnson RA, and Fedinec AL. Contributions of prostacyclin and nitric oxide to carbon monoxide induced cerebrovascular dilation in newborn pigs. Am J Physiol Heart Circ Physiol 280: H1490–H1495, 2001.[Abstract/Free Full Text]
  84. Leffler CW, Nasjletti A, Yu C, Johnson RA, Fedinec AL, and Walker N. Carbon monoxide and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol 276: H1641–H1646, 1999.[Abstract/Free Full Text]
  85. Li Volti G, Ientile R, Abraham NG, Vanella A, Cannavo G, Mazza F, Curro M, Raciti G, Avola R, and Campisi A. Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochem Biophys Res Commun 315: 517–524, 2004.[CrossRef][Web of Science][Medline]
  86. Li Volti G, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck JR, and Abraham NG. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 7: 704–710, 2005.[CrossRef][Web of Science][Medline]
  87. Linden DJ, Narasimhan K, and Gurfel D. Protoporphyrins modulate voltage-gated Ca current in AtT-20 pituitary cells. J Neurophysiol 70: 2673–2677, 1993.[Abstract/Free Full Text]
  88. Liu N, Wang X, McCoubrey WK, and Maines MD. Developmentally regulated expression of two transcripts for heme oxygenase-2 with a first exon specific to rat testis; control by corticosterone of the oxygenase protein expression. Gene 241: 175–183, 2000.[CrossRef][Web of Science][Medline]
  89. Liu Q, Xu Q, Arcuino G, Kang J, and Nedergaard M. Astrocyte-mediated activation of neuronal kainite receptors. Proc Natl Acad Sci USA 101: 3172–3177, 2004.[Abstract/Free Full Text]
  90. Liu XM, Chapman GB, Peyton KJ, Schafer AI, and Durante W. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55: 396–405, 2002.[Abstract/Free Full Text]
  91. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, and Kourembanas S. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer. J Biol Chem 273: 15257–15262, 1998.[Abstract/Free Full Text]
  92. Maines MD, Eke BC, and Zhao X. Corticosterone promotes increase heme oxygenase-2 protein and transcript expression in newborn rat. Brain Res 722: 83–94, 1996.[CrossRef][Web of Science][Medline]
  93. Maines MD. Carbon monoxide: an emerging regulator of cGMP in the brain. Mol Cell Neurosci 4: 389–397, 1993.[CrossRef]
  94. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517–554, 1997.[CrossRef][Web of Science][Medline]
  95. Maines MD. The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46: 573–585, 2000.[Web of Science][Medline]
  96. Mark JA and Maines MD. Tin-protoporphyrin-mediated disruption in vivo of heme-oxygenase-2 protein integrity and activity in the rat brain. Pediatr Res 32: 324–329, 1992.[Web of Science][Medline]
  97. Marks GS, Brien JF, Nakatsu K, and McGlaughlin BE. Does carbon monoxide have a biological function? Trends Pharmacol Sci 12: 185–188, 1991.[CrossRef][Medline]
  98. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, and Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279: 8919–8929, 2004.[Abstract/Free Full Text]
  99. Maulik N, Engelman DT, Watanabe M, Engelman RM, and Das DK. Nitric oxide—a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem 157: 75–86, 1996.[CrossRef][Web of Science][Medline]
  100. May BK, Bhasker CR, Bawden MJ, and Cox TC. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis. Mol Biol Med 7: 405–421, 1990.[Web of Science][Medline]
  101. McCoubrey WK, Huang TJ, and Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725–732, 1997.[Web of Science][Medline]
  102. Meffert MK, Haley JE, Schuman EM, Schulman H, and Madison DV. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13: 1225–1233, 1994.[CrossRef][Web of Science][Medline]
  103. Meldrum BS. Concept of activity-induced cell death in epilepsy: historical, and contemporary perspectives. Prog Brain Res 135: 3–11, 2002.[Medline]
  104. Minetti M, Mallozzi C, Di Stasi AM, and Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352: 165–174, 1998.[CrossRef][Web of Science][Medline]
  105. Montecot C, Seylaz J, and Pinard E. Carbon monoxide regulates cerebral blood flow in epileptic seizures but not in hypercapnia. Neuroreport 9: 2341–2346, 1998.[Web of Science][Medline]
  106. Morita T, Mitsialis SA, Koike H, Liu Y, and Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272: 32804–32809, 1997.[Abstract/Free Full Text]
  107. Morita T, Perrella MA, Lee ME, and Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92: 1475–1479, 1995.[Abstract/Free Full Text]
  108. Morley P, Small DL, Murray CL, Mealing GA, Poulter MO, Durkin JP, and Stanimirovic DB. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J Cereb Blood Flow Metab 18: 396–406, 1998.[CrossRef][Web of Science][Medline]
  109. Motterlini R, Foresti R, Intaglietta M, and Winslow RW. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol Heart Circ Physiol 270: H107–H114, 1996.[Abstract/Free Full Text]
  110. Naik JS and Walker BR. Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization. Am J Physiol Heart Circ Physiol 285: H220–H228, 2003.[Abstract/Free Full Text]
  111. Nguyen T, Sherratt PJ, and Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43: 233–260, 2003.[CrossRef][Web of Science][Medline]
  112. Ny L, Andersson KE, and Grundemar L. Inhibition by zinc protoporphyrin-IX of receptor-mediated relaxation of the rat aorta in a manner distinct from inhibition of haem oxygenase. Br J Pharmacol 115: 186–190, 1995.[Web of Science][Medline]
  113. Pace NR. A molecular view of microbial diversity and the biosphere. Science 276: 734–740, 1997.[Abstract/Free Full Text]
  114. Paravicini TM and Soby CG. Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase. Clin Exp Pharmacol Physiol 30: 855–859, 2003.[CrossRef][Web of Science][Medline]
  115. Parfenova H, Daley ML, Carratu P, and Leffler CW. Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. Brain Res 1014: 87–96, 2004.[CrossRef][Web of Science][Medline]
  116. Parfenova H, Fedinec A, and Leffler CW. Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase. J Cereb Blood Flow Metab 23: 190–197, 2003.[CrossRef][Web of Science][Medline]
  117. Parfenova H, Neff RA III, Alonso JS, Shlopov BV, Jamal CN, Sarkasova SA, and Leffler CW. Cerebrovascular endothelial heme oxygenase: expression, intracellular compartmentalization, and activation by glutamate. Am J Physiol Cell Physiol 281: C1954–C1963, 2001.[Abstract/Free Full Text]
  118. Parfenova H, Zuckerman Z, and Leffler CW. Inhibitory effect of indomethacin on prostacyclin receptor-mediated cerebral vascular responses. Am J Physiol Heart Circ Physiol 268: H1184–H1890, 1995.
  119. Parfenova H, Carratu P, Tcheranova D, Fedinec A, Pourcyrous M, and Leffler CW. Epileptic seizures cause extended cerebral vascular dysfunction that is prevented by HO-1 overexpression. Am J Physiol Heart Circ Physiol 288: H2843–H2850, 2005.[Abstract/Free Full Text]
  120. Pelligrino DA, Baughman VL, and Koenig HM. Nitric oxide and the brain. Int Anesthesiol Clin 34: 113–132, 1996.[Web of Science][Medline]
  121. Philip S and Armstead WM. NMDA dilates pial arteries by KATP and KCa channel activation. Brain Res Bull 63: 127–131, 2004.[CrossRef][Web of Science][Medline]
  122. Pourcyrous M, Bada H, Parfenova H, Daley M, Korones S, and Leffler CW. Cerebrovasodilatory contribution of endogenous carbon monoxide during seizures in newborn pigs. Pediatr Res 51: 579–585, 2002.[CrossRef][Web of Science][Medline]
  123. Robinson JS, Fedinec AL, and Leffler CW. Role of CO in glutamate receptor-induced dilation of newborn pig pial arterioles. Am J Physiol Heart Circ Physiol 282: H2371–H2376, 2002.[Abstract/Free Full Text]
  124. Rosenblum WI. ATP-sensitive potassium channels in the cerebral circulation. Stroke 34: 1547–1552, 2003.[Abstract/Free Full Text]
  125. Ryter SW and Choi AMK. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 4: 625–632, 2002.[CrossRef][Web of Science][Medline]
  126. Sachse C and Echeverri CJ. Oncology studies using siRNA libraries: the dawn of RNAi-based genomics. Oncogene 23: 8384–8391, 2004.[CrossRef][Web of Science][Medline]
  127. Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, Green CJ, and Motterlini R. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 125: 1437–1444, 1998.[CrossRef][Web of Science][Medline]
  128. Scanlon KJ. Anti-genes: siRNA, ribozymes and antisense. Curr Pharm Biotechnol 5: 415–420, 2004.[CrossRef][Web of Science][Medline]
  129. Scapagnini G, D'Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, and Cavallaro S. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954: 51–59, 2002.[CrossRef][Web of Science][Medline]
  130. Schuller DJ, Wilks A, Ortiz de Montellano PR, and Poulos TL. Crystal structure of human heme oxygenase-1. Nat Struct Biol 6: 860–867, 1999.[CrossRef][Web of Science][Medline]
  131. Serfass L and Burstyn JN. Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity. Arch Biochem Biophys 359: 8–16, 1998.[CrossRef][Web of Science][Medline]
  132. Shan X, Dunbrack RL Jr, Christopher SA, and Kruger WD. Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis. Hum Mol Genet 10: 635–643, 2001.[Abstract/Free Full Text]
  133. Sharp CD, Hines I, Houghton J, Warren A, Jackson 4th TH, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, and Alexander JS. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol 285: H2592–H2598, 2003.[Abstract/Free Full Text]
  134. Sharp CD, Houghton J, Elrod JW, Warren A, Jackson 4th TH, Jawahar A, Nanda A, Minagar A, and Alexander JS. N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am J Physiol Heart Circ Physiol 288: H1893–H1899, 2005.[Abstract/Free Full Text]
  135. Simandle SA, Kerr BA, Lacza Z, Eckman DM, Busija DW, and Bari F. Piglet pial arteries respond to N-methyl-D-aspartate in vivo but not in vitro. Microvasc Res 70: 76–83, 2005.[CrossRef][Web of Science][Medline]
  136. Soares MP, Usheva A, Brouard S, Berberat PO, Gunther L, Tobiash E, and Bach FH. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 4: 321–328, 2002.[CrossRef][Web of Science][Medline]
  137. Solnyshkova TG and Shakhlamov VA. Ultrastructural and morphometric characteristics of nerve cells and myelinated fibers in the cerebral cortex after chronic exposure to natural gas containing hydrogen sulfide in low concentrations. Bull Exp Biol Med 134: 411–413, 2002.[CrossRef][Web of Science][Medline]
  138. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, Flavell RA, Billiar TR, Otterbein LE, and Choi AM. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172: 1220–1226, 2004.[Abstract/Free Full Text]
  139. Song R, Zhou Z, Kim PK, Shapiro RA, Liu F, Ferran C, Choi AM, and Otterbein LE. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem 279: 44327–44334, 2004.[Abstract/Free Full Text]
  140. Tang XD, Rong X, Reynolds MF, Garcia ML, Heinemann SM, and Hoshi T. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 425: 531–535, 2003.[CrossRef][Medline]
  141. Thorup C, Jones CL, Gross SS, Moore LC, and Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol Renal Physiol 277: F882–F889, 1999.[Abstract/Free Full Text]
  142. Tulis DA. Salutary properties of YC-1 in the cardiovascular and hematological systems. Curr Med Chem 2: 343–359, 2004.
  143. Undem BJ, Ellis JL, Meeker S, Fischer A, and Canning BJ. Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea. J Pharmacol Exp Ther 278: 964–970, 1996.[Abstract/Free Full Text]
  144. Wang R, Wang Z, and Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121: 927–934, 1997.[CrossRef][Web of Science][Medline]
  145. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5: 493–501, 2003.[CrossRef][Web of Science][Medline]
  146. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792–1798, 2002.[Abstract/Free Full Text]
  147. Wang R and Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272: 8222–8226, 1997.[Abstract/Free Full Text]
  148. Weber CM, Eke BC, and Maines MD. Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J Neurochem 63: 953–962, 1994.[Web of Science][Medline]
  149. Wendling WW, Chen D, Daniels FB, Monteforte MR, Fischer MB, Harakal C, and Carlsson C. The effects of N-methyl-D-aspartate agonists and antagonists on isolated bovine cerebral arteries. Anesth Analg 82: 264–268, 1996.[Abstract]
  150. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, Peers C, and Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306: 2093–2097, 2004.[Abstract/Free Full Text]
  151. Winestone JS, Bonner C, and Leffler CW. Carbon monoxide as an attenuator of vasoconstriction in piglet cerebral circulation. Exp Biol Med (Maywood) 228: 46–50, 2003.[Abstract/Free Full Text]
  152. Wu L, Cao K, Lu Y, and Wang R. Different mechanisms underlying the stimulation of KCa channels by nitric oxide and carbon monoxide. J Clin Invest 110: 691–700, 2002.[CrossRef][Web of Science][Medline]
  153. Xi Q, Tcheranova D, Parfenova H, Horowitz B, Leffler CW, and Jaggar JH. Carbon monoxide activates KCa channels in newborn arteriole smooth muscle cells by increasing apparent Ca2+ sensitivity of {alpha}-subunits. Am J Physiol Heart Circ Physiol 286: H610–H618, 2004.[Abstract/Free Full Text]
  154. Yang G, Cao K, and Wang R. Cystathionine {gamma}-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK–1. J Biol Chem 279: 49199–49205, 2004.[Abstract/Free Full Text]
  155. Yang G, Sun X, and Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of MAP kinases and caspase-3. FASEB J 18: 1782–1784, 2004.[Abstract/Free Full Text]
  156. Yang G, Zhang Y, Ross ME, and Iadecola C. Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase. Am J Physiol Heart Circ Physiol 285: H298–H304, 2003.[Abstract/Free Full Text]
  157. Yuan ZR, Liu B, Zhang Y, Yuan L, Muteliefu G, and Lu J. Upregulated expression of neuronal nitric oxide synthase by insulin in both neurons and astrocytes. Brain Res 1008: 1–10, 2004.[CrossRef][Web of Science][Medline]
  158. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, and Snyder SH. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA 93: 795–798, 1996.[Abstract/Free Full Text]
  159. Zhang F, Kaide J, Wei Y, Jiang H, Yu C, Balazy M, Abraham NG, Wang W, and Nasjletti A. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 281: H350–H358, 2001.[Abstract/Free Full Text]
  160. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248–1258, 2003.[Abstract/Free Full Text]
  161. Zhao W and Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474–H480, 2002.[Abstract/Free Full Text]
  162. Zhao W, Ndisang JF, and Wang R. Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol 81: 848–853, 2003.[CrossRef][Web of Science][Medline]
  163. Zhao W, Zhang J, Lu Y, and Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008–6016, 2001.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
StrokeHome page
A. Kanu and C. W. Leffler
Roles of Glia Limitans Astrocytes and Carbon Monoxide in Adenosine Diphosphate-Induced Pial Arteriolar Dilation in Newborn Pigs
Stroke, March 1, 2009; 40(3): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. F. Perry, B. McNeill, E. Elia, A. Nagpal, and B. Vulesevic
Hydrogen sulfide stimulates catecholamine secretion in rainbow trout (Oncorhynchus mykiss)
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R133 - R140.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
K. R. Olson
Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control
J. Exp. Biol., September 1, 2008; 211(17): 2727 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Jha, J. W. Calvert, M. R. Duranski, A. Ramachandran, and D. J. Lefer
Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H801 - H806.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
E. S. Roberts, R. S. Thomas, and D. C. Dorman
Gene Expression Changes Following Acute Hydrogen Sulfide (H2S)-induced Nasal Respiratory Epithelial Injury
Toxicol Pathol, June 1, 2008; 36(4): 560 - 567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. L. Whitfield, E. L. Kreimier, F. C. Verdial, N. Skovgaard, and K. R. Olson
Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1930 - R1937.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. C. Holt, A. L. Fedinec, A. N. Vaughn, and C. W. Leffler
A BRIEF COMMUNICATION: Age and Species Dependence of Pial Arteriolar Responses to Topical Carbon Monoxide In Vivo
Experimental Biology and Medicine, December 1, 2007; 232(11): 1465 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Zimmermann, C. W. Leffler, D. Tcheranova, A. L. Fedinec, and H. Parfenova
Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2501 - H2507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Koenitzer, T. S. Isbell, H. D. Patel, G. A. Benavides, D. A. Dickinson, R. P. Patel, V. M. Darley-Usmar, J. R. Lancaster Jr, J. E. Doeller, and D. W. Kraus
Hydrogen sulfide mediates vasoactivity in an O2-dependent manner
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1953 - H1960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. W. Leffler, H. Parfenova, A. L. Fedinec, S. Basuroy, and D. Tcheranova
Contributions of astrocytes and CO to pial arteriolar dilation to glutamate in newborn pigs
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2897 - H2904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Basuroy, S. Bhattacharya, D. Tcheranova, Y. Qu, R. F. Regan, C. W. Leffler, and H. Parfenova
HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-{alpha} in cerebral vascular endothelial cells
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C897 - C908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Parfenova, S. Basuroy, S. Bhattacharya, D. Tcheranova, Y. Qu, R. F. Regan, and C. W. Leffler
Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection
Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1399 - C1410.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leffler, C. W.
Right arrow Articles by Wang, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leffler, C. W.
Right arrow Articles by Wang, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.